Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Harmony Energy Income Trust 'minded to recommend' £190.8m takeover by Foresight

(Sharecast News) - Harmony Energy Income Trust said on Monday that it was "minded to recommend" a £190.8m takeover proposal from investment manager Foresight Group LLP. Under the terms of the deal, HEIT shareholders would receive 84p per share in cash. This is a 29% premium to the closing share price on Friday and a 76% premium to the closing share price on 29 May 2024, which was the last business day prior to the date of the announcement of HEIT's asset sale process.

HEIT previously said it had made "substantial" progress through its ongoing asset sale process towards the conclusion of a definitive agreement to sell its entire portfolio to a third party.

However, it said on Monday that having carefully considered the possible cash offer with its advisers, the board has concluded that it would deliver "a superior outcome" for shareholders.

"As a result, the HEIT board has indicated to Foresight that, should a firm offer be made on the financial terms set out above, it would be minded to recommend such an offer to HEIT shareholders, subject to the agreement of the other terms of the offer.

"Accordingly, the HEIT board is engaging in discussions with Foresight to finalise those terms."

Under UK takeover rules, Foresight now has until 1700 GMT on 14 April to either announce a firm intention to make an offer for HEIT or walk away.

At 1155 GMT, the shares were up 22% at 79.22p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.